| Followers | 1 |
| Posts | 47 |
| Boards Moderated | 0 |
| Alias Born | 11/26/2013 |
Thursday, April 10, 2014 2:10:34 PM
Murphy gave a nice presentation. I suspect the entire reason for the show today was in response to the general investment community (and maybe some high powered shareholders) showing a little anxiousness. (Maybe it was our child millionaire/prodigy poster here on the thread talking about the technicals and his prognostication...and the CFO decided that snot nosed little wannabe wasn't going to peg the downfall of ONVO, so he retaliated, lol...) So anyway, the CFO truly had his ear to the ground, got this presentation organized and hoped it quelled some fears....The 10K this morning was a bone thrown with just enough meat to show that the ONVO employees are not sitting around getting stoned, surfing porn at work
My Personal summary (from a LT shareholder standpoint):
There is no reason to sell - and there is reason to continue accumulation. I heard nothing indicating they're hitting a wall in R&D or are changing their focus - as a matter of fact, they seem to have alot of confidence and seem to be expanding their scope.
I suspect SP will continue to drift, pulled by manipulation and the resulting emotion up and down. I think we're 6-8 months off from seeing sustained SP creep upward. So be it.
Later in the Q and A, Murphy noted a $12M annual burn rate against an approximate $50M capital availability balance. So that averages out to 4 years of working capital/Expense. Realistically, I think it's enough to hold them for a year or two and to also cover Production ramp, expansion, ect... I would bet in another year we see some shares issued, but I hope it's at a point where the SP and volume easily absorbs an increase with little impact to the SP...
I was surfing this early morning when I saw the 10K hit. I read it and was encouraged, monitoring the pre-market. Was a little taken back at the lack of strength after the open and was thinking of taking a small amount off the table at 8.50, but decided to wait for Murphy to speak. Got into work and noticed a 60 cent dip...oh well, too late. Doesn't really matter - I have a fair amount already...why get greedy?...
Back to LT hold, will grab some popcorn and watch the jerk arounds on Yahoo fro a while...
Regards
My Personal summary (from a LT shareholder standpoint):
There is no reason to sell - and there is reason to continue accumulation. I heard nothing indicating they're hitting a wall in R&D or are changing their focus - as a matter of fact, they seem to have alot of confidence and seem to be expanding their scope.
I suspect SP will continue to drift, pulled by manipulation and the resulting emotion up and down. I think we're 6-8 months off from seeing sustained SP creep upward. So be it.
Later in the Q and A, Murphy noted a $12M annual burn rate against an approximate $50M capital availability balance. So that averages out to 4 years of working capital/Expense. Realistically, I think it's enough to hold them for a year or two and to also cover Production ramp, expansion, ect... I would bet in another year we see some shares issued, but I hope it's at a point where the SP and volume easily absorbs an increase with little impact to the SP...
I was surfing this early morning when I saw the 10K hit. I read it and was encouraged, monitoring the pre-market. Was a little taken back at the lack of strength after the open and was thinking of taking a small amount off the table at 8.50, but decided to wait for Murphy to speak. Got into work and noticed a 60 cent dip...oh well, too late. Doesn't really matter - I have a fair amount already...why get greedy?...
Back to LT hold, will grab some popcorn and watch the jerk arounds on Yahoo fro a while...
Regards
Recent VIVS News
- VivoSim Platform Predicts Gastrointestinal Toxicity (Diarrhea) in an AI Model Trained on Human Intestinal Model Results – Without Animal Testing • GlobeNewswire Inc. • 04/28/2026 12:05:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 04/06/2026 05:27:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/03/2026 08:05:10 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 04/02/2026 08:00:55 PM
- VivoSim Announces Pricing of up to a $4 Million Public Offering • GlobeNewswire Inc. • 04/01/2026 12:05:00 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 03/31/2026 02:17:06 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 03/27/2026 09:26:52 PM
- VivoSim Releases Antibody Drug Conjugate (ADC) Data Showing Power to Detect ADC Toxicity and Guide Design of Safer ADCs • GlobeNewswire Inc. • 03/24/2026 12:05:00 PM
- VivoSim Appoints Arumugham (Ragoo) Raghunathan as Vice President of Global Sales • GlobeNewswire Inc. • 03/03/2026 01:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/11/2026 09:05:26 PM
- VivoSim to Debut Antibody Drug Conjugate Data, representing a major new market for NAMkind models, at Society of Toxicology Meeting in San Diego • GlobeNewswire Inc. • 02/11/2026 01:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2026 12:59:09 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2026 12:51:43 AM
- VivoSim Expands Asia-Pacific Access to NAMKind™ Human-Based Toxicology Services Through New Distributor Agreement in Korea and China • GlobeNewswire Inc. • 01/29/2026 09:05:00 PM
- VivoSim Labs Appoints Amar Sethi, M.D., Ph.D. as Chief Scientific Officer • GlobeNewswire Inc. • 01/06/2026 01:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2025 09:05:25 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 11/26/2025 11:07:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2025 09:01:04 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2025 09:08:13 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/03/2025 09:07:49 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/03/2025 09:06:32 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/28/2025 08:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/22/2025 12:45:18 AM
